Vaniqa (Eflornithine) Administration

Topical Administration (Vaniqa™ cream)

• For topical use only. To reduce hair growth in facial and chin areas only. Do not apply to areas surrounding the eyes or to mucous membranes (e.g., mouth, nose, pubic area, etc.).
  
• The patient should continue to use hair removal techniques as needed; eflornithine is not a depilatory. Topical eflornithine should be applied >= 5 minutes after hair removal.
  
• Cosmetics or sunscreens may be applied over treated areas after the cream has dried.

- Full Story - »»»    

Vaniqa (Eflornithine)

Ornidyl®, Vaniqa, Vaniqa Cream(Cream 13.9 %)

Classification:
Dermatological Agents

• Pigmentation Agents

- Full Story - »»»    

Related entries

• Patients should consult before stopping Pfizer drug-FDA
• Zytiga (abiraterone acetate)
• Roche melanoma drug extends life more than a yr-study
• Glaxo melanoma drug combo shows promise in small trial
• OraSure surges on recommendation for HIV test
• FDA approves 20 minute take-home HIV test
• Achillion’s hepatitis C drug gets FDA fast track
• Roche Alzheimer’s drug picked for major test
• FDA says unsure if Novartis MS pill caused deaths
• French drugmaker on trial over weight-loss pill
• Study raises questions about use of anti-epilepsy drugs in newborns
• FDA panel backs Gilead’s Truvada to prevent HIV
• Novartis to probe Indian drug approval allegations
• Novartis eye drug efficient over longer term: studies
• FDA warns MS patients about risky treatment

Monthly Archives

• May 2012
• April 2012
• March 2012
• February 2012
• May 2008
• November 2007
• October 2007
• September 2007
• July 2007
• March 2007
• October 2006
• September 2006
• August 2006
• July 2006
• June 2006
• May 2006
• April 2006
• March 2006
• February 2006
• January 2006
• December 2005
• November 2005
• October 2005
• September 2005
• Complete Archives

Syndicate